论文信息 - Updated Follow-up of the Alta Study, a Phase 1/2, Open Label, Adaptive, Dose-Ranging Study to Assess the Safety and Tolerability of SB-525 Gene Therapy in Adult Patients with Severe Hemophilia A - 字舞流文

Updated Follow-up of the Alta Study, a Phase 1/2, Open Label, Adaptive, Dose-Ranging Study to Assess the Safety and Tolerability of SB-525 Gene Therapy in Adult Patients with Severe Hemophilia A

A. Leavitt | D. Rouy | B. Konkle | S. Arkin | T. Harrington | K. Stine | N. Visweshwar | G. D. Di Russo | A. Giermasz | A. Snyder | A. Woolfson | Gregory Di Russo